This review focuses on the gastric acid pump as a therapeutic target for th
e control of acid secretion in peptic ulcer and gastro-oesophageal reflux d
isease. The mechanism of the proton pump inhibitors is discussed as well as
their clinical use. The biology of Helicobacter pylori as a gastric denize
n is then discussed, with special regard to its mechanisms of acid resistan
ce. Here the properties of the products of the urease gene clusters, ureA,
B and ureI, E, F, G and H are explored in order to explain the unique locat
ion of this pathogen. The dominant requirement for acid resistance is the p
resence of a proton gated urea transporter, UreI, which increases access of
gastric juice urea to the intrabacterial urease 300-fold. This enables rap
id and continuous buffering of the bacterial periplasm to approximate to pH
6.0, allowing acid resistance and growth at acidic pH in the presence of 1
mM urea. A hypothesis for the basis of combination therapy for eradication
is also presented.